Poly(lactic-co-glycolic acid) (PLGA) based microparticles (MPs) are widely investigated for their ability to load a range of molecules with high efficiency, including antigenic proteins, and release them in a controlled manner. Micron-sized PLGA MPs are readily phagocytosed by antigen presenting cells, and localized to endosomes. Due to low pH and digestive enzymes, encapsulated protein cargo is largely degraded and processed in endosomes for MHC-II loading and presentation to CD4 
| I N T R O D U C T I O N
Biomaterials have traditionally been developed to avoid provoking chronic aggravation of the immune system. 1 This complex network of cellular interactions and processes has evolved to provide protection against foreign invaders as well as homeostatic regulation of self to nonself. Strategies that aim to manipulate components of the immune system, particularly polymer-based vaccines, have gained attention in recent years. [1] [2] [3] [4] Polymeric microparticles (MPs) offer a distinct advantage as their intrinsic immunomodulatory properties and chemical versatility fulfill desired properties in achieving long-term protection.
Generation of protective immunity following vaccination depends on antigen availability, delivery to antigen presenting cells (APCs) and further activation of innate immunity through the appropriate pathways. vectors limits their use in infants, the elderly and the immunocompromised. 6 Conversely, recombinant antigens based on peptides hold high potential for CD8 1 T cell vaccine development but their dependency on adjuvants remains a major hurdle to clinical translation. 7 In this study, we develop a unique polymer blend for the fabrication of microparticles that allow for the tuning of CD4 1 and CD8 1 T cell responses through targeting of dendritic cells (DCs). We hypothesize incorporation of a small amount of Poly(2-propylacrylic acid) (PPAA) into a poly (lactic-co-glycolic acid) (PLGA) matrix, will lead to endosomal escape triggering cross-presentation pathway within DCs and further activa- Microparticles fabricated of PLGA are one of the most widely used PPAA/PLGA blend MPs were fabricated with a modified protocol.
PPAA (100 mg) were dissolved in 2 ml of DMF while 90 mg of PLGA were dissolved in 1.8 ml of MC for 10% PPAA/PLGA blend or 97 mg 
| Mice
The studies reported here conform to the animal welfare ACT and the 
| Isolation and culture of murine bone marrow dendritic cells
Dendritic cells were derived from mouse bone marrow as previously described. 11 In brief, mice were euthanized by CO 2 asphyxiation followed by cervical dislocation. Tibias and femurs were harvested and marrow cells collected by flushing the shafts of the bones with a 25-g needle using wash media (RPMI medium containing 10% heat inactivated filter sterilized fetal bovine serum, and 1% penicillin-streptomycin) and mixed to obtain a single-cell suspension. The solution was then strained through a 70 mm cell strainer and centrifuged at 1,700 rpm for 5 min at 48C. Erythrocytes were then removed by resuspending in ACK lysis buffer for 5 min at room temperature and centrifuging at the conditions specified above. Resulting cells were cultured in DC media (complete DMEM/F12 medium containing 2.5 mM L-glutamine, 100 U/ml penicillin-streptomycin, 10% heat inactivated filter sterilized FBS, 1 mM sodium pyruvate, and 1x NEAA mixture and 20 ng/ml GM-CSF). Monocytes were selected by plastic adherence for 6 days at 378C with 95% relative humidity and 5% CO 2 . The culture was 
| T cell proliferation assay by flow cytometry
On day 8 of culture, DCs were seeded with OVA-loaded PLGA-based microparticles at a 50:1 ratio (MPs: cells) and incubated for an additional 2 days. On day 10, CD4 1 and CD8 1 T cells were isolated from the spleen of OT-I and OT-II 8-week old female mice. Briefly, animals were euthanized by CO 2 asphyxiation followed by cervical dislocation.
Spleens were aseptically harvested and homogenized in wash media.
Cells were then passed through a 70 mm cell strainer and centrifuged at 1,700 rpm for 5 min at 48C. Red blood cells were eliminated using ACK lysis buffer followed by centrifugation to recover lymphocytes.
CD4
1 and CD8 1 T cells were purified using a negative selection isolation kit according to manufacturer's instructions. Resulting cells were stained with 5 mM CFSE for 10 min at room temperature to track proliferation. DCs were washed of particles three times with warm PBS and relevant groups pulsed with 100 ll of 2 lg/ml OVA peptides, 323-339 or 257-264, in DC media for 3 hr. DCs and T cells were cocultured for 4 days at a 1:10 ratio with a half media change on day 2.
On the specified days, T cells were collected by centrifugation, washed with PBS containing 1% FBS, stained with live/dead NIR dye, and antibodies against surface markers CD4 or CD8 for 30 min at 48C and fixed with BD Cytofix fixation buffer for 20 min at 48C. Proliferation was measured by CFSE dilution using a Guava EasyCyte (EMD Millipore) flow cytometer. Data analysis was performed using FCS Express version 3 (De Novo Software, Los Angeles, CA).
| Statistical analysis
Data reported were analyzed and charts were generated using Prism 5.0 (GraphPad, San Diego, CA). Statistics were done using a one-way ANOVA followed by Tukey's post hoc analysis to make pair-wise comparisons, with 95% confidence intervals. Two-way ANOVA was used to determine differences in T cell proliferation with a Bonferroni's post hoc analysis. Unless otherwise indicated, data represent the mean 6 SEM, with p < .05 considered statistically significant. On completion of the 30-day incubation, total cumulative ovalbumin released from MPs was 62.4 6 2.1% for PLGA, 81.9 6 2.4% for 3%
| R E S U L T S 3.1 | Microparticle characterization
PPAA/PLGA blend, and 91.2 6 1.8% for 10% PPAA/PLGA blend. However, the complete release of the theoretical maximum encapsulated OVA in the three types of MPs was not achieved over the course of the study (Figure 3 ).
| PPAA-mediated endosomal disruption
The PPAA-mediated endosomal escape was examined by micros- formulations over the course of the study (Figure 4b) . Interestingly, the 10% PPAA/PLGA blend MPs showed promoted cytosolic localization in the first day with 7.9 6 2.5% FITC area/DC area, compared to 3.2 6 2.4%, and 0.6 6 0.2% for the 3% blend and the PLGA only formulations, respectively. Although PLGA only MPs were also able to escape the endosome to some degree, a significant increase was observed with both the 3 and 10% blend. The capacity to disrupt endosomal membranes increased directly proportional to the percentage of PPAA in the particle formulation.
3.3 | Antigen-specific T cell proliferation study 
| DISCUSSION
This study has provided a novel approach to endosomal escape strategies, enabling the tuning of antigen delivery to either endosomal or cytosolic compartments to shape subsequent CD4 enzymatic degradation, [18] [19] [20] pH, 21, 22 and light. 23 In addition to these efforts, biodegradable polymeric delivery systems have attracted significant attention due to their loading capability, low toxicity, and ease of use. A number of studies have shown that particle size, particle charge, and delivery site have an impact on uptake and immune stimulation. [24] [25] [26] [27] Nanometer-scale particles can be taken up through pinocytosis, a mechanism not exclusive to APCs, whereas particles larger than 7 mm are not efficiently engulfed, and the cargo released in the extracellular space. 28 These studies, in combination with previous work in our lab, 10, [29] [30] [31] [32] LITERATURE CITED
